Cargando…
Circulating EVs long RNA-based subtyping and deconvolution enable prediction of immunogenic signatures and clinical outcome for PDAC
Identification of clinically applicable molecular subtypes of pancreatic ductal adenocarcinoma (PDAC) is crucial to improving patient outcomes. However, the traditional tissue-dependent transcriptional subtyping strategies are invasive and not amenable to routine clinical evaluation. In this study,...
Autores principales: | Li, Yuchen, Li, Ye, Yu, Shulin, Qian, Ling, Chen, Kun, Lai, Hongyan, Zhang, Hena, Li, Yan, Zhang, Yalei, Gu, Sijia, Meng, Zhiqiang, Huang, Shenglin, Wang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479278/ https://www.ncbi.nlm.nih.gov/pubmed/34631279 http://dx.doi.org/10.1016/j.omtn.2021.08.017 |
Ejemplares similares
-
EV-origin: Enumerating the tissue-cellular origin of circulating extracellular vesicles using exLR profile
por: Li, Yuchen, et al.
Publicado: (2020) -
Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection
por: Dai, Manxiong, et al.
Publicado: (2022) -
Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
por: Pervin, Jannat, et al.
Publicado: (2023) -
ENO1 expression and Erk phosphorylation in PDAC and their effects on tumor cell apoptosis in a hypoxic microenvironment
por: Sun, Huizhi, et al.
Publicado: (2022) -
Deconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purpose
por: Li, Jingjing, et al.
Publicado: (2015)